Cover Image
市場調查報告書

全球miRNA市場

Global miRNA Market 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 318853
出版日期 內容資訊 英文 80 Pages
訂單完成後即時交付
價格
Back to Top
全球miRNA市場 Global miRNA Market 2015-2019
出版日期: 2014年11月12日 內容資訊: 英文 80 Pages
簡介

微型核糖核酸(miRNA),是用轉譯階段抑制基因表現的單鏈非編碼RNA分子。全球miRNA市場,預計2014年∼2019年的以13.36%的年複合成長率增加。

本報告提供全球miRNA市場相關調查分析、市場規模與成長率、市場趨勢、推動市場要素與課題、市場機會驗證、主要供應商等相關的系統性資訊。

第1章 摘要整理

第2章 簡稱清單

第3章 調查範圍

  • 市場概要
  • 主要的產品

第4章 市場調查手法

  • 市場調查流程
  • 調查手法

第5章 簡介

第6章 市場形勢

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第7章 市場區隔:各用途

  • 全球miRNA研究市場
    • 市場規模與預測
  • 全球miRNA為基礎的診斷市場
    • 市場規模與預測
  • 全球miRNA為基礎的治療市場
    • 開發平台概要

第8章 地區區分

  • 南北美洲的miRNA市場
    • 市場規模與預測
  • 歐洲、中東、非洲地區的miRNA市場
    • 市場規模與預測
  • 亞太地區的miRNA市場
    • 市場規模與預測

第9章 購買標準

第10章 推動市場成長要素

第11章 推動因素與其影響

第12章 市場課題

第13章 推動因素與課題的影響

第14章 市場趨勢

第15章 趨勢與其影響

第16章 業者情勢

  • 競爭模式
    • 主要消息
    • M&A
  • 供應商分析
  • 其他卓越供應商

第17章 主要供應商分析

  • Affymetrix Inc.
  • Agilent Technologies
  • Exiqon A/S
  • Qiagen
  • Thermo Fisher Scientific

第18章 相關報告

圖表

目錄
Product Code: IRTNTR4698

About miRNAs

miRNAs are single-stranded, small, non-coding RNA molecules that regulate gene expression at the translation level. They play a vital role in research, diagnostics, and therapeutics to study expression of genes and to control diseases by gene silencing. They interact with mRNA molecules and regulate expression of genes by mRNA cleavage, translational repression, and deadenylation. They are generally 17-27 nucleotides long and regulate post-transcriptional mRNA expression by binding to the 3' untranslated region of the mRNA sequence, which results in translational suppression and gene silencing. miRNAs are involved in a wide range of biological processes, including apoptosis, cell cycle control, and several developmental processes such as stem cell differentiation, hypoxia, hematopoiesis, neurogenesis, insulin secretion, cardiac and skeletal muscle development, aging, cholesterol metabolism, viral replication, and immune responses. They can be used as therapeutics for the treatment of some severe diseases including cancer and genetic disorders by introducing specific miRNAs into diseased cells to silence the defective gene.

TechNavio's analysts forecast the Global miRNA market to grow at a CAGR of 13.36 percent over the period 2014-2019.

Covered in this Report

The Global miRNA market can be divided into different segments based on application: miRNA Research, miRNA-based Diagnostics, and Therapeutics

TechNavio's report, Global miRNA Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global miRNA market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Affymetrix
  • Agilent Technologies
  • Exiqon
  • Qiagen
  • Thermo Fisher Scientific

Other Prominent Vendors

  • Alnylam Pharmaceuticals
  • Aparna Biosciences
  • Applied Biological Materials
  • AstraZeneca Pharmaceuticals
  • Biogen Idec
  • Bio-Rad Laboratories
  • F. Hoffmann-La Roche
  • Firefly Bioworks
  • Fluidigm
  • Genecopoeia
  • Genosensor
  • Gensignia
  • Glaxosmithkline
  • Groove Biopharma
  • HTG Molecular Diagnostics
  • Idera Pharmaceuticals
  • Illumina
  • Integrated DNA Technologies
  • InteRNA Technologies
  • LC Sciences
  • EMD Millipore
  • Miltenyi Biotec
  • miRagen Therapeutics
  • Mirna Therapeutics
  • Nanostring Technologies
  • Norgen Biotek
  • Novartis
  • Origene Technologies
  • Pfizer
  • Phalanx Biotech
  • Prolias Technologies
  • Quark Pharmaceuticals
  • Regulus Therapeutics
  • Rosetta Genomics
  • RXi Pharmaceuticals
  • Sanofi
  • Santaris Pharma (Acquired by Roche)
  • Silence Therapeutics
  • System Biosciences
  • Takara Bio
  • Tekmira Pharmaceuticals
  • Theradiag
  • WaferGen Biosystems
  • Wako Pure Chemical Industries

Market Driver

  • Increased Investment in miRNA-based Research and Drug Development
  • For a full, detailed list, view our report

Market Challenge

  • Delivery of miRNA-based Drugs
  • For a full, detailed list, view our report

Market Trend

  • Increased M&A
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be
  • What are the key market trends
  • What is driving this market
  • What are the challenges to market growth
  • Who are the key vendors in this market space
  • What are the market opportunities and threats faced by the key vendors
  • What are the strengths and weaknesses of the key vendors

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Market Segmentation by Application

  • 07.1. Global miRNA Research Market
    • 07.1.1. Market Size and Forecast
  • 07.2. Global miRNA-based Diagnostics Market
    • 07.2.1. Market Size and Forecast
  • 07.3. Global miRNA-based Therapeutics Market
    • 07.3.1. Pipeline Snapshot

08. Geographical Segmentation

  • 08.1. miRNA Market in Americas
    • 08.1.1. Market Size and Forecast
  • 08.2. miRNA Market in EMEA Region
    • 08.2.1. Market Size and Forecast
  • 08.3. miRNA Market in APAC Region
    • 08.3.1. Market Size and Forecast

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape

  • 16.1. Competitive Scenario
    • 16.1.1. Key News
    • 16.1.2. Mergers and Acquisitions
  • 16.2. Vendor Analysis 2013
  • 16.3. Other Prominent Vendors

17. Key Vendor Analysis

  • 17.1. Affymetrix Inc.
    • 17.1.1. Key Facts
    • 17.1.2. Business Overview
    • 17.1.3. Business Segmentation
    • 17.1.4. Business Segmentation by Revenue 2013
    • 17.1.5. Business Segmentation by Revenue 2012 and 2013
    • 17.1.6. Sales by Geography
    • 17.1.7. Business Strategy
    • 17.1.8. Key Information
    • 17.1.9. SWOT Analysis
  • 17.2. Agilent Technologies
    • 17.2.1. Key Facts
    • 17.2.2. Business Overview
    • 17.2.3. Business Segmentation by Revenue 2013
    • 17.2.4. Business Segmentation by Revenue 2012 and 2013
    • 17.2.5. Geographical Segmentation by Revenue 2013
    • 17.2.6. Business Strategy
    • 17.2.7. Recent Developments
    • 17.2.8. SWOT Analysis
  • 17.3. Exiqon A/S
    • 17.3.1. Key Facts
    • 17.3.2. Business Overview
    • 17.3.3. Business Segmentation by Revenue 2013
    • 17.3.4. Business Segmentation by Revenue 2012 and 2013
    • 17.3.5. Geographical Segmentation by Revenue 2013
    • 17.3.6. Business Strategy
    • 17.3.7. Recent Developments
    • 17.3.8. SWOT Analysis
  • 17.4. Qiagen
    • 17.4.1. Key Facts
    • 17.4.2. Business Overview
    • 17.4.3. Product Segmentation by Revenue 2013
    • 17.4.4. Product Segmentation by Revenue 2012 and 2013
    • 17.4.5. Geographical Segmentation by Revenue 2013
    • 17.4.6. Business Strategy
    • 17.4.7. Recent Developments
    • 17.4.8. SWOT Analysis
  • 17.5. Thermo Fisher Scientific
    • 17.5.1. Key Facts
    • 17.5.2. Business Overview
    • 17.5.3. Business Segmentation
    • 17.5.4. Product Segmentation by Revenue
    • 17.5.5. Sales Segmentation
    • 17.5.6. Business Strategy
    • 17.5.7. Key Information
    • 17.5.8. SWOT Analysis

18. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global miRNA Market 2014-2019 (US$ million)
  • Exhibit 3: Global miRNA Market Segmentation by Application
  • Exhibit 4: Global miRNA Research Market 2014-2019 (US$ million)
  • Exhibit 5: Global miRNA-based Diagnostics Market 2014-2019 (US$ million)
  • Exhibit 6: Global miRNA Market Segmentation by Application 2014-2019 (US$ million)
  • Exhibit 7: Global miRNA Market Segmentation by Application 2014-2019
  • Exhibit 8: Percentage split of the Global miRNA Therapeutics Pipeline 2013
  • Exhibit 9: Global miRNA Market Segmentation by Geography 2014
  • Exhibit 10: miRNA Market in Americas 2014-2019 (US$ million)
  • Exhibit 11: miRNA Market in EMEA Region 2014-2019 (US$ million)
  • Exhibit 12: miRNA Market in APAC Region 2014-2019 (US$ million)
  • Exhibit 13: Global miRNA Market Segmentation by Geography 2014-2019 (US$ million)
  • Exhibit 14: Global miRNA Market Segmentation by Geography 2014-2019
  • Exhibit 15: Affymetrix Inc.: Business Segmentation 2013
  • Exhibit 16: Affymetrix Inc. 2013: Business Segmentation by Revenue 2013
  • Exhibit 17: Affymetrix Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 18: Affymetrix Inc.: Sales by Geography 2013
  • Exhibit 19: Agilent Technologies: Business Segmentation by Revenue 2013
  • Exhibit 20: Agilent Technologies: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 21: Agilent Technologies: Geographical Segmentation by Revenue 2013
  • Exhibit 22: Exiqon: Business Segmentation by Revenue 2013
  • Exhibit 23: Exiqon: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 24: Exiqon: Geographical Segmentation by Revenue 2013
  • Exhibit 25: Qiagen: Product Segmentation by Revenue 2013
  • Exhibit 26: Qiagen: Product Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 27: Qiagen: Geographical Segmentation by Revenue 2013
  • Exhibit 28: Thermo Fisher Scientific: Business Segmentation by Revenue 2013
  • Exhibit 29: Thermo Fisher Scientific: Product Segmentation by Revenue 2013
  • Exhibit 30: Thermo Fisher Scientific: Sales by Geography 2013
Back to Top